Evidence map›Paper›PMID 32433683›Full record

ArticlePLoS neglected tropical diseases2020

Association of NOD2 and IFNG single nucleotide polymorphisms with leprosy in the Amazon ethnic admixed population.

André Luiz Leturiondo, Ariani Batista Noronha, Carla Yael Ribeiro Mendonça, Cynthia de Oliveira Ferreira, Lucia Elena Alvarado-Arnez, Fernanda Saloum de Neves Manta, Ohanna Cavalcanti de Lima Bezerra, Elizeu Fagundes de Carvalho, Milton Ozório Moraes, Fabíola da Costa Rodrigues and 1 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

André Luiz LeturiondoPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.ORCID 0000-0002-7202-5579
Ariani Batista NoronhaLaboratório de Biologia Molecular, Fundação Alfredo da Matta, Manaus, Brazil.
Carla Yael Ribeiro MendonçaLaboratório de Biologia Molecular, Fundação Alfredo da Matta, Manaus, Brazil.
Cynthia de Oliveira FerreiraLaboratório de Biologia Molecular, Fundação Alfredo da Matta, Manaus, Brazil.
Lucia Elena Alvarado-ArnezCoordinación de Investigación, Universidad Franz Tamayo/UNIFRANZ, La Paz, Bolivia.
Fernanda Saloum de Neves MantaLaboratório de Hanseníase, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brazil.
Ohanna Cavalcanti de Lima BezerraLaboratório de Hanseníase, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brazil.
Elizeu Fagundes de CarvalhoLaboratório de Diagnóstico por DNA, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Milton Ozório MoraesLaboratório de Hanseníase, Instituto Oswaldo Cruz-Fiocruz, Rio de Janeiro, Brazil.
Fabíola da Costa RodriguesLaboratório de Biologia Molecular, Fundação Alfredo da Matta, Manaus, Brazil.
Carolina TalhariPrograma de Pós-Graduação em Medicina Tropical, Universidade do Estado do Amazonas, Manaus, Brazil.
Fundação Getulio Vargas · BRFundação Oswaldo Cruz · BRUniversidade do Estado do Amazonas · BRUniversidade do Estado do Rio de Janeiro · BRUniversidade Nilton Lins · BRUniversidad Privada Franz Tamayo · BO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leprosy is a chronic infectious disease, caused by Mycobacterium leprae, which affects skin and peripheral nerves. Polymorphisms in genes associated with autophagy, metabolism, innate and adaptive immunity confer susceptibility to leprosy. However, these associations need to be confirmed through independent replication studies in different ethnicities. The population from Amazon state (northern Brazil) is admixed and it contains the highest proportion of Native American genetic ancestry in Brazil. We conducted a case-control study for leprosy in which we tested fourteen previously associated SNPs in key immune response regulating genes: TLR1 (rs4833095), NOD2 (rs751271, rs8057341), TNF (rs1800629), IL10 (rs1800871), CCDC122/LACC1 (rs4942254), PACRG/PRKN (rs9356058, rs1040079), IFNG (rs2430561), IL6 (rs2069845), LRRK2 (rs7298930, rs3761863), IL23R (rs76418789) and TYK2 (rs55882956). Genotyping was carried out by allelic discrimination in 967 controls and 412 leprosy patients. Association with susceptibility was assessed by logistic regression analyses adjusted for the following covariates: gender, age and ancestry. Genetic ancestry was similar in case and control groups. Statistically significant results were only found for IFNG and NOD2. The rs8057341 polymorphism within NOD2 was identified as significant for the AA genotype (OR = 0.56; 95% CI, 0.37-0.84; P = 0.005) and borderline for the A allele (OR = 0.76; 95% CI, 0.58-1.00; P = 0.053) and carrier (OR = 0.76; 95% CI, 0.58-1.00; P = 0.051). The rs2430561 SNP in IFNG was associated with disease susceptibility for the AT genotype (OR = 1.40; 95% CI, 1.06-1.85; P = 0.018) and carrier (OR = 1.44; 95% CI, 1.10-1.88; P = 0.008). We confirmed that NOD2 and IFNG are major players in immunity against M.leprae in the Amazon ethnic admixed population.

Indexed as

Genetic Predisposition to DiseasePolymorphism, Single NucleotideAdultAgedBrazilCase-Control StudiesFemaleGenotyping TechniquesHumansInterferon-gammaLeprosyMaleMiddle AgedNod2 Signaling Adaptor ProteinYoung AdultIFNG protein, humanInterferon-gammaNOD2 protein, humanNod2 Signaling Adaptor Protein

Identifiers

PMID32433683
PMCPMC7239438
OpenAlexW3027023408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.